100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
Previously searched by you
TEST BANK FOR Pharmacotherapeutics for Advanced Practice: A Practical Approach 5TH edition by Virginia Poole Arcangelo, Andrew Peterson | perfect solution |2023/2024R281,69
Add to cart
Pharmacotherapeutics For Advanced Practice A Pract
Pharmacotherapeutics For Advanced Practice A Pract
Exam (elaborations)
TEST BANK FOR Pharmacotherapeutics for Advanced Practice: A Practical Approach 5TH edition by Virginia Poole Arcangelo, Andrew Peterson | perfect solution |2023/2024
26 views 2 purchases
Course
Pharmacotherapeutics For Advanced Practice A Pract
Institution
Pharmacotherapeutics For Advanced Practice A Pract
Book
Pharmacotherapeutics for Advanced Practice
TEST BANK FOR Pharmacotherapeutics for Advanced Practice: A Practical Approach 5TH edition by Virginia Poole Arcangelo, Andrew Peterson |perfect solution |2023/2024
TEST BANK FOR Pharmacotherapeutics for Advanced Practice: A Practical Approach 5TH edition by Virginia Poole Arcangelo, Andrew Peterson|| All Chapters 1-60|| Newest Edition
Pharmacotherapeutics for Advanced Practice- A Practical Approach 5th Edition Arcangelo Test Bank LATEST
Test Bank For Pharmacotherapeutics for Advanced Practice- A Practical Approach 5th Edition Arcangelo |complete solution| guide A+.
All for this textbook (27)
Written for
Pharmacotherapeutics For Advanced Practice A Pract
Pharmacotherapeutics For Advanced Practice A Pract
Seller
Follow
Kylaperfect
Reviews received
Content preview
TEST BANK FOR
Pharmacotherapeutics for Advanced Practice: A
Practical Approach 5th Edition, Kindle Edition
by Virginia Poole Arcangelo , Andrew Peterson , Veronica Wilbur
, Table of Contents
Chapter 1 Issues for the Practitioner in Drug Therapy .................................................................................. 4
Chapter 2. Pharmacokinetic Basis of Therapeutics andPharmacodynamic .................................................. 5
Chapter 3. Impact of Drug Interactions and Adverse Events onTherapeutics ............................................ 10
Chapter 4. Principles of Pharmacotherapy in Children ............................................................................... 14
Chapter 5. Principles of Pharmacotherapy in Pregnancy and ..................................................................... 15
Chapter 6. Principles of Pharmacotherapy in Elderly Patients ................................................................... 20
Chapter 7 Principles of Pharmacotherapy in Pain ....................................................................................... 21
Chapter 8. Principles of Antimicrobial Therapy ......................................................................................... 25
Chapter 9. Complementary and Alternative Medicines .............................................................................. 28
Chapter 10. Pharmacogenomics .................................................................................................................. 30
Chapter 11. Contact Dermatitis ................................................................................................................. 33
Chapter 12. Fungal Infections of the Skin ................................................................................................... 35
Chapter 13 Viral Infections of the Skin ...................................................................................................... 37
Chapter 14 Bacterial Infections of the Skin ................................................................................................ 38
Chapter 15. Psoriasis ................................................................................................................................... 42
Chapter 16. Acne Vulgaris and Rosacea ..................................................................................................... 43
Chapter 17 Ophthalmic Disorders ............................................................................................................... 44
Chapter 18 OPHTHLAMIC DISORDERS ................................................................................................. 47
Chapter 19. Hypertension............................................................................................................................ 50
Chapter 20. Hyperlipidemia ........................................................................................................................ 53
Chapter 21. Angina .................................................................................................................................... 56
Chapter 22. Heart Failure ............................................................................................................................ 60
Chapter 23. Dysrhythmias ........................................................................................................................... 62
Chapter 24 Upper Respiratory Infections.................................................................................................... 65
Chapter 25. Asthma ................................................................................................................................... 67
Chapter 26. Chronic Obstructive Pulmonary Disease ................................................................................. 69
Chapter 27. Bronchitis and Pneumonia ....................................................................................................... 70
Chapter 28. Nausea and Vomiting ............................................................................................................ 71
Chapter 29. Gastroesophageal Reflux Disease and Peptic Ulcer Disease ................................................... 73
Chapter 30. Constipation Diarrhea and Irritable Bowel Syndrome............................................................. 75
Chapter 31 Inflammatory Bowel Disease ................................................................................................... 77
Chapter 32. Urinary Tract Infections .......................................................................................................... 78
Chapter 34. Overactive Bladder .................................................................................................................. 80
Chapter 35. Sexually Transmitted Infections .............................................................................................. 82
Chapter 36. Osteoarthritis and Rheumatoid Arthritis .................................................................................. 84
Chapter 37. Fibromyalgia ............................................................................................................................ 86
Ch 38. Headaches ........................................................................................................................................ 87
Chapter 39 Seizure Disorders ...................................................................................................................... 90
, Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANS: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANS: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANS: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
ANS: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level
ANS: A PTS: 1
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through EFT, credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying this summary from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Kylaperfect. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy this summary for R281,69. You're not tied to anything after your purchase.
